Psychological aspects of presymptomatic diagnosis of spinocerebellar ataxia type 2 in Cuba

Community Genetics

Volumn 10, Issue 3, 2007, Pages 132-139

  Paneque, H M ^a,c   Prieto, A L ^a   Reynaldo, R R ^a   Cruz, M T ^a   Santos, F N ^a   Almaguer, M L ^a   Velazquez P L ^a   Heredero, B L ^b  

^a Centro para la Investigacion y Rehabilitacion de las Ataxias Hereditarias Cuba   (Cuba)

^b National Center of Medical Genetics   (Cuba)

^c NONE   (Cuba)

Author keywords

Hereditary ataxias; Presymptomatic diagnosis; Psychosocial genetics; Spinocerebellar ataxia type 2

Indexed keywords

ADULT; ANXIETY; CONTROLLED STUDY; CUBA; DEPRESSION; FAMILY PLANNING; FEMALE; GENETIC ANALYSIS; GENETIC RISK; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT INFORMATION; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SOCIAL SUPPORT; SPINOCEREBELLAR DEGENERATION; SYMPTOM;

ADAPTATION, PSYCHOLOGICAL; ADULT; DISEASE PROGRESSION; EMOTIONS; FEMALE; GENETIC COUNSELING; HUMANS; INFORMED CONSENT; INTERVIEWS; MALE; MEDICAL RECORDS; MIDDLE AGED; MOTIVATION; PATIENT CARE TEAM; PILOT PROJECTS; PSYCHOLOGICAL TESTS; SOCIOECONOMIC FACTORS; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEATS;

EID: 34250619737     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101754     Document Type: Review

References (23)

1. Orozco G, Estrada R, Perry TL, Arana J, Fernandez R, Gonzalez-Quevedo A, Galarraga J, Hansen S: Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings. J Neurol Sci 1989;93:37-50.
2. Orozco DG, Nodarse FA, Cordovés R, Aurburger G: Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holguin, Cuba. Neurology 1990;40:1369-1375.
3. Velázquez PL, Santos FN, García R, Paneque HM, Hechavarría PR: Epidemiología de la ataxia hereditaria cubana. Neurología 2001;32606-611.
4. Gispert S, Twells R, Orozco G, Brice A, Wever J, Heredero L: Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chro mosome 12q23-24.1. Nat Genet 1993;4:295-299.
5. Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, Lopes-Cendes I, Pearlman S, Starkman S, Orozco-Diaz G, Lunkes A, DeJong P, Rouleau GA, Auburger G, Korenberg JR, Figueroa C, Sahba S: Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 1996;14:269-276.
6. European Community Huntington Disease Collaborative Study Group: Ethical and social issues in presymptomatic testing for Huntington's disease. A European Community collaborative study. J Med Genet 1993;30:1028-1035.
7. Sequeiros J: Protocolo geral do Programa Nacional de Teste Preditivo e Aconselhamento Genético na Doença de Machado-Joseph; in Sequeiros J (ed): O Teste Preditivo da Doença de Machado-Joseph. Porto, UnIGENe, 1996, pp 123-149.
8. Nance MA, Leroy BS, Orr HT, Parker T, Rich SS, Heston LL: Protocol for genetic testing in Huntington disease: three years of experience in Minnesota. Am J Med Genet 1991;40:518-522.
9. Harper PS, Lim C, Craufurd D: Ten years of presymptomatic tests for Huntington's disease: the experience of the UK. Huntington Disease Prediction Consortium. J Med Genet 2000;37:567-571.
10. Solís-Pérez MP, Burguera JA, Palau F, Livianos L, Vila M, Rojo L: Resultados de un programa de diagnóstico presintomático en la enfermedad de Huntington: evaluación de un período de 6 años. Neurología 2001;16:348-352.
11. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
12. Spielberger CD, Gorsuch RL, Lushene RE: Manual for the Trait Anxiety Inventory. Palo Alto, Consulting Psychological Press, 1970.
13. Ortega VT, de la Cuesta FD, Días RC: Propuesta de un instrumento para la aplicación del proceso de atención de enfermería en familias disfuncionales. Rev Cub Enfermería 1999;15:164-168.
14. Rodriguez-Marín J, Terol MC, Lopez-Roig S, y Pastor MA: Evaluación del afrontamiento del estrés: propiedades psicométricas del cuestionario de Formas de Afrontamiento de Acontecimientos Estresantes. Rev Psicol Salud 1992;4:59-84.
15. Almqvist EW, Bloch M, Brinkman R, Craufurd D, Hayden MR, on behalf of the international HD collaborative group: A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington's disease. Am J Hum Genet 1999;64:1293-1304.
16. Al-Jader LN, Harper PS, Krawczak M, Palmer SR: The frequency of inherited disorders database: prevalence of Huntington disease. Community Genet 2001;4:148-157.
17. Sobel S, Cowan D: Impact of genetic testing for Huntington disease on the family system. Am J Med Gen 2000;90:49-59.
18. Kessler S: Forgotten person in the Huntington disease family. Am J Med Genet 1993;48:145-150.
19. Binedell J, Soldan JR, Harper PS: Predictive testing for Huntington's disease. 2. Qualitative findings from a study of uptake in South Wales. Clin Genet 1998;54:489-496.
20. Tibben A: What is knowledge but grieving? On psychological effects of presymptomatic DNA-testing for Huntington's disease; PhD thesis, Erasmus University, Rotterdam, 1993.
21. Huggins M, Bloch M, Wiggins S, Adam S, Suchowersky O, Trew M, Klimek ML, Greenberg CR, Eleff M, Thompson LP, Knight J, MacLeod P, Girard K, Theilmann J, Hedrick A, Hayden MR: Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet 1992;42:508-515.
22. Tibben A, Frets PG, Van de Kamp JJ, Niermeijer MF, Vegter-van der Vlis M, Roos RA, Rooymans HG, Van Ommen GJ, Verhage F: On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program. Am J Med Genet 1993;48:103-111.
23. Tibben A, Roos RA, Niermeijer MF: Psychological consequences of presymptomatic testing for Hunting Huntington's disease. Lancet 1997;349:809.